Changeflow GovPing Healthcare Patent Application: In Vivo Tissue Diagnosis Us...
Routine Notice Added Draft

Patent Application: In Vivo Tissue Diagnosis Using Optical Spectroscopy

Favicon for changeflow.com ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B)
Published July 7th, 2025
Detected March 30th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083331A1) from Florida International University Board of Trustees for devices and methods for in vivo tissue diagnosis using optical spectroscopy and indentation. The application details systems that utilize intrinsic tissue properties to detect disease and injury.

What changed

This document is a published patent application (US20260083331A1) from the USPTO, filed by The Florida International University Board of Trustees. It describes systems, devices, and methods for in vivo tissue diagnosis that combine optical spectroscopy to assess morphological and compositional characteristics with an indentation method to measure mechanical properties. The goal is to detect disease and/or injury development in tissues using intrinsic properties, potentially with a portable, handheld device.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future innovation and intellectual property in the medical device and healthcare sectors. Companies involved in diagnostic tools, medical devices, or healthcare technology may wish to monitor the progress of this patent application and similar filings for competitive intelligence and potential licensing or partnership opportunities.

Source document (simplified)

← USPTO Patent Applications

DEVICES AND METHODS FOR IN VIVO TISSUE DIAGNOSIS

Application US20260083331A1 Kind: A1 Mar 26, 2026

Assignee

The Florida International University Board of Trustees

Inventors

Wei-Chiang Lin, Anamika Prasad

Abstract

Systems, devices, and methods for in vivo tissue diagnosis are provided. Optical spectroscopy can be utilized to characterize the morphological and/or compositional characteristics of in vivo tissue, and an indentation method can be used to measure the mechanical characteristics of the tissue. These intrinsic properties can then be used to detect disease and/or injury development in the in vivo tissue. A portable, handheld device can be used to perform the optical spectroscopy and/or the indentation method.

CPC Classifications

A61B 5/0075 A61B 5/441 A61B 5/442

Filing Date

2025-07-07

Application No.

19261449

View original document →

Named provisions

Abstract Assignee Inventors

Classification

Agency
USPTO
Published
July 7th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083331A1

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Medical Device Development Diagnostic Technology
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Medical Devices Intellectual Property

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.